Showing results (161-170 of 182) with videos related to

Sort By:
Pageof 19
Annals of Translational Medicine|January 20, 2023
Aerobic exercise reverses the NF-κB/NLRP3 inflammasome/5-HT pathway by upregulating irisin to alleviate post-stroke depressionXue-Qin Tang, Ruo-Yi Liao, Li-Jun Zheng, et al.
European Journal of Medicinal Chemistry|June 7, 2011
Combined SVM-based and docking-based virtual screening for retrieving novel inhibitors of c-MetQing-Qing Xie, Lei Zhong, You-Li Pan, et al.
International Journal of Systematic and Evolutionary Microbiology|September 8, 2017
Bacillus endozanthoxylicus sp. nov., an endophytic bacterium isolated from Zanthoxylum bungeanum Maxim leavesLi Ma, Jia-Qin Xi, Yong-Hong Cao, et al.
Scientific Reports|October 27, 2015
SKLB-677, an FLT3 and Wnt/β-catenin signaling inhibitor, displays potent activity in models of FLT3-driven AMLShuang Ma, Ling-Ling Yang, Ting Niu, et al.
Current Microbiology|May 27, 2025
Bacteria in the Phylum Bacillota Degrade Nicotine Through the Variant of Pyridine and Pyrrolidine PathwayXiu-Ming Liu, Xuan Hai, Cong-Jian Li, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|July 23, 2013
SC-535, a novel oral multikinase inhibitor, showed potent antitumor activity in human melanoma modelsXin Chen, Pan Ji, Hui-Wen Yang, et al.
Plants (Basel, Switzerland)|October 26, 2024
Pharmacological Potential and Electrochemical Characteristics of Typha angustifolia PollenJanielle Mari S Abadilla, Bor-Yann Chen, Mike Anthony D Ganzon, et al.
European Journal of Medicinal Chemistry|June 30, 2018
X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cellsLing-Ling Yang, Hua-Li Wang, Lei Zhong, et al.
Medchemcomm|February 19, 2019
Crystallographic and SAR analyses reveal the high requirements needed to selectively and potently inhibit SIRT2 deacetylase and decanoylaseLing-Ling Yang, Wei Xu, Jie Yan, et al.
International Journal of Cancer|May 3, 2014
A preclinical evaluation of a novel multikinase inhibitor, SKLB-329, as a therapeutic agent against hepatocellular carcinomaLei Zhong, Xiao-Yu Fu, Chan Zou, et al.
Pageof 19